158 related articles for article (PubMed ID: 36180926)
1. TRIM3 and TRIM16 as potential tumor suppressors in breast cancer patients.
Roshanazadeh MR; Adelipour M; Sanaei A; Chenane H; Rashidi M
BMC Res Notes; 2022 Sep; 15(1):312. PubMed ID: 36180926
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Tripartite Motif Containing 16 Expression in Patients with Gastric Cancer.
Afshar J; Mehrzad J; Mehrad-Majd H; Goshayeshi L; Saeidi J
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2445-2451. PubMed ID: 34452557
[TBL] [Abstract][Full Text] [Related]
3. Changes in the Expression of Long Non-Coding RNA SDMGC and Its Target Gene, TRIM16, in Patients with Gastric Cancer.
Seifi Inallou M; Safaralizadeh R; Rajabi A; Hosseinpourfeizi M; Haghi M
J Gastrointest Cancer; 2023 Mar; 54(1):44-50. PubMed ID: 34978663
[TBL] [Abstract][Full Text] [Related]
4. Tripartite motif 16 suppresses breast cancer stem cell properties through regulation of Gli-1 degradation via the ubiquitin-proteasome pathway.
Yao J; Xu T; Tian T; Fu X; Wang W; Li S; Shi T; Suo A; Ruan Z; Guo H; Yao Y
Oncol Rep; 2016 Feb; 35(2):1204-12. PubMed ID: 26718507
[TBL] [Abstract][Full Text] [Related]
5. TRIM16 overexpression inhibits the metastasis of colorectal cancer through mediating Snail degradation.
Ruan L; Liu W; Yang Y; Chu Z; Yang C; Yang T; Sun J
Exp Cell Res; 2021 Sep; 406(1):112735. PubMed ID: 34265287
[TBL] [Abstract][Full Text] [Related]
6. Divergent self-association properties of paralogous proteins TRIM2 and TRIM3 regulate their E3 ligase activity.
Esposito D; Dudley-Fraser J; Garza-Garcia A; Rittinger K
Nat Commun; 2022 Dec; 13(1):7583. PubMed ID: 36481767
[TBL] [Abstract][Full Text] [Related]
7. TRIM16 protects human periodontal ligament stem cells from oxidative stress-induced damage via activation of PICOT.
Zhao Y; Liu H; Xi X; Chen S; Liu D
Exp Cell Res; 2020 Dec; 397(1):112336. PubMed ID: 33091421
[TBL] [Abstract][Full Text] [Related]
8. Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer.
Huang XQ; Zhang XF; Xia JH; Chao J; Pan QZ; Zhao JJ; Zhou ZQ; Chen CL; Tang Y; Weng DS; Zhang JH; Xia JC
Chin J Cancer; 2017 Sep; 36(1):77. PubMed ID: 28950898
[TBL] [Abstract][Full Text] [Related]
9. Tripartite Motif 16 Inhibits the Migration and Invasion in Ovarian Cancer Cells.
Tan H; Qi J; Chu G; Liu Z
Oncol Res; 2017 Apr; 25(4):551-558. PubMed ID: 27737724
[TBL] [Abstract][Full Text] [Related]
10. TRIM16 acts as an E3 ubiquitin ligase and can heterodimerize with other TRIM family members.
Bell JL; Malyukova A; Holien JK; Koach J; Parker MW; Kavallaris M; Marshall GM; Cheung BB
PLoS One; 2012; 7(5):e37470. PubMed ID: 22629402
[TBL] [Abstract][Full Text] [Related]
11. CircPTK2 inhibits cell cisplatin (CDDP) resistance by targeting miR-942/TRIM16 axis in non-small cell lung cancer (NSCLC).
Wang Y; Wu Y; Xie S
Bioengineered; 2022 Feb; 13(2):3651-3664. PubMed ID: 35230201
[TBL] [Abstract][Full Text] [Related]
12. CRABP2 accelerates epithelial mesenchymal transition in serous ovarian cancer cells by promoting TRIM16 methylation via upregulating EZH2 expression.
Xie T; Tan M; Gao Y; Yang H
Environ Toxicol; 2022 Aug; 37(8):1957-1967. PubMed ID: 35442568
[TBL] [Abstract][Full Text] [Related]
13. Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development.
Piao MY; Cao HL; He NN; Xu MQ; Dong WX; Wang WQ; Wang BM; Zhou B
Scand J Gastroenterol; 2016; 51(5):572-82. PubMed ID: 26691157
[TBL] [Abstract][Full Text] [Related]
14. High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients.
Kim PY; Tan O; Liu B; Trahair T; Liu T; Haber M; Norris MD; Marshall GM; Cheung BB
Cancer Lett; 2016 May; 374(2):315-23. PubMed ID: 26902425
[TBL] [Abstract][Full Text] [Related]
15. Tripartite motif-containing protein 3 plays a role of tumor inhibitor in cervical cancer.
Song Y; Guo Q; Gao S; Hua K
Biochem Biophys Res Commun; 2018 Apr; 498(3):686-692. PubMed ID: 29524410
[TBL] [Abstract][Full Text] [Related]
16. Heterozygous loss of keratinocyte TRIM16 expression increases melanocytic cell lesions and lymph node metastasis.
Sutton SK; Cheung BB; Massudi H; Tan O; Koach J; Mayoh C; Carter DR; Marshall GM
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2241-2250. PubMed ID: 31342168
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of TRIM3 is associated with poor prognosis in patients with primary hepatocellular carcinoma.
Chao J; Zhang XF; Pan QZ; Zhao JJ; Jiang SS; Wang Y; Zhang JH; Xia JC
Med Oncol; 2014 Aug; 31(8):102. PubMed ID: 24994609
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of TRIM3 gene predicts a poor prognosis in gastric cancer.
Farhadi J; Goshayeshi L; Motavalizadehkakhky A; Mehrzad J; Mehrad-Majd H
J Gastrointest Cancer; 2022 Mar; 53(1):179-186. PubMed ID: 33415720
[TBL] [Abstract][Full Text] [Related]
19. Advances in the antitumor mechanisms of tripartite motif-containing protein 3.
Teng W; Ling Y; Liu Z; Jiang L; Fu G; Zhou X; Long N; Liu J; Chu L
J Cancer Res Clin Oncol; 2024 Feb; 150(2):105. PubMed ID: 38411731
[TBL] [Abstract][Full Text] [Related]
20. Tripartite motif-containing 3 (TRIM3) enhances ER signaling and confers tamoxifen resistance in breast cancer.
Ye R; AiErken N; Kuang X; Zeng H; Shao N; Lin Y; Liu P; Wang S
Oncogenesis; 2021 Sep; 10(9):60. PubMed ID: 34508066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
